Inflection Biosciences
is a developer of small molecule therapeutics for the treatment of cancer... Read moreInflection Biosciences
is a developer of small molecule therapeutics for the treatment of cancer... Read more
News
Aug 25, 2023
BizPlus
Inflection Biosciences: Inflection Biosciences licenses IP to Mysthera Therapeutics
Oct 19, 2020
MarketScreener
Inflection Biosciences: Inflection Biosciences Announces Appointment of Gregory I. Berk, MD, to its Board of Directors
Jul 19, 2019
The Pharma Letter
Inflection Biosciences: BRIEF-Inflection out-licenses oncology candidate
Jul 18, 2019
BioSpace
Inflection Biosciences: Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors
Jul 18, 2019
THE IRISH TIMES
Inflection Biosciences: Irish company Inflection sells cancer drug to Singapore group
Jul 17, 2019
Business Wire
Press Release: Inflection Biosciences : AUM Biosciences Expands Pipeline With Global License for First-in-class Targeted Cancer Therapy
Nov 02, 2018
THE IRISH TIMES
Inflection Biosciences: Irish drug company signs research deal with Texas university
Nov 01, 2018
PharmiWeb
Inflection Biosciences: Inflection Biosciences Announces Research Collaboration with MD Anderson
Nov 01, 2018
PharmiWeb
Inflection Biosciences: Company Profile for Inflection Biosciences Ltd
Aug 10, 2018
BioPortfolio
Inflection Biosciences: Inflection Biosciences Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
